Skip to main content
Caplight Logo









BioSurfaces, LLC

BioSurfaces, LLC

Private
Ashland, MassachusettsHealthcare & Life Scienceshttps://www.biosurfaces.us/

Last Round

Grant

Nov 22, 2024

Total Funding Raised

$3.78M

Company Overview

BioSurfaces, LLC is a biotechnology company that develops and manufactures nanofiber-based biomaterials, medical devices, and in vitro research tools using its proprietary Bio-Spun™ electrospinning technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

electrospinningnanofiber materialsbiomimetic scaffoldstissue engineeringdrug-eluting implantsregenerative medicineextracellular matrixin vitro researchcell therapy deliverybiotech materialsmedical device componentsbiomaterialsnanofabricationdrug delivery systemsscaffold technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioSurfaces, LLC Comparables

Compare BioSurfaces, LLC with similar companies based on industry and business-model similarity.

BioSurfaces, LLC comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The Electrospinning Company Ltd.
84%
KLISBio
79%
Matregenix
78%

BioSurfaces, LLC Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 22, 2024
Series ADec 8, 2022

Key People

Founding team and executive leadership

Matthew Phaneuf

President and CEO

Executive Team

BioSurfaces, LLC Investors

Notable investors and investment history

BioSurfaces, LLC investors
InvestorRounds
NOVA by Saint-GobainSeries A
NIH RADxGrant
Gates FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 7, 2025

    Monthly visitors increased 54% MoM.

  • Jul 23, 2025

    Grew 23% QoQ from 13 to 16 employees.

BioSurfaces, LLC Filings

Explore SEC and related filing metadata, where available.

BioSurfaces, LLC filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioSurfaces, LLC's valuation, stock price, and market status.

Is BioSurfaces, LLC a public or private company?

BioSurfaces, LLC is a private company.

What is the current stock price of BioSurfaces, LLC?

BioSurfaces, LLC is a private company with no public stock price. No recent secondary market data is available.

How much is BioSurfaces, LLC worth (valuation)?

Valuation information for BioSurfaces, LLC is not publicly available.

Can I buy BioSurfaces, LLC stock?

BioSurfaces, LLC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioSurfaces, LLC's last funding round?

BioSurfaces, LLC's most recent funding round was Grant on November 22, 2024.

Who are the main investors in BioSurfaces, LLC?

Key investors in BioSurfaces, LLC include NOVA by Saint-Gobain.

Will BioSurfaces, LLC IPO soon?

No public IPO plans have been announced for BioSurfaces, LLC.

How can I track BioSurfaces, LLC secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioSurfaces, LLC's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAshland, Massachusetts
Employee Range12
Year FoundedN/A
Last FundingNov 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?